Endovascular treatments for ischemic stroke
https://doi.org/10.17802/2306-1278-2022-11-3-188-198
Abstract
Highlights. Mechanical thrombectomy is the “gold standard” treatment of patients with large-vessel occlusions. Five randomized trials conducted in 2015 made a significant contribution to the development and introduction of mechanical thrombectomy into clinical practice. The DAWN and DEFUSE-3 trials have provided new insights into the pathophysiology of ischemic stroke and ensured the advancement in the therapeutic field.
Abstract. Stroke is one of the leading causes of death and disability worldwide. The general strategy for the treatment of ischemic stroke is aimed at restoring blood flow to the ischemic regions of the brain. Intravenous thrombolysis has been the treatment for acute ischemic stroke since 1996. However, since 2015, as a result of 5 randomized trials, endovascular mechanical thrombectomy has become the gold standard for the treatment of patients with large cerebral artery occlusion. The DAWN and DEFUSE 3 trials have provided new insights into the pathophysiology of ischemic stroke, shifting the paradigm from “time = brain” to “collaterals = brain”. In this article, the authors will consider development of endovascular devices, modern mechanical thrombectomy techniques, and directions for further research of endovascular treatment for ischemic stroke.
About the Authors
D. U. Malaev
State Novosibirsk Regional Clinical Hospital
Russian Federation
Competing Interests:
Russian Federation
Dastan U. Malaev - Specialist in Endovascular Diagnostics and Treatment at the State Novosibirsk Regional Clinical Hospital.
130, St. Nemirovich-Danchenko, Novosibirsk, 630087.
Competing Interests:
Автор заявляет об отсутствии конфликта интересов.
N. I. Grachev
Primorsk Regional Clinical Hospital № 1
Russian Federation
Competing Interests:
Russian Federation
Nikita I. Grachev - PhD, Specialist in Endovascular Diagnostics and Treatment at the Primorsk Regional Clinical Hospital № 1.
57, Aleutskaya St., Vladivostok, 690091.
Competing Interests:
Автор заявляет об отсутствии конфликта интересов.
D. A. Redkin
State Novosibirsk Regional Clinical Hospital
Russian Federation
Competing Interests:
Russian Federation
Dmitry A. Redkin - Specialist in Endovascular Diagnostics and Treatment at the State Novosibirsk Regional Clinical Hospital.
130, St. Nemirovich-Danchenko, Novosibirsk, 630087.
Competing Interests:
Автор заявляет об отсутствии конфликта интересов.
References
1. Feigin V.L., Forouzanfar M.H., Krishnamurthi R., Mensah G.A., Connor M., Bennett D.A., Moran A.E., Sacco R.L., Anderson L., Truelsen T., O'Donnell M., Venketasubramanian N., Barker-Collo S., Lawes C.M., Wang W., Shinohara Y., Witt E., Ezzati M., Naghavi M., Murray C.; Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383(9913):245-54. doi: 10.1016/s0140-6736(13)61953-4.
2. Paciaroni M., Balucani C., Agnelli G., Caso V., Silvestrelli G., Grotta J.C., Demchuk A.M., Sohn S.I., Orlandi G., Leys D. et al. Systemic thrombolysis in patients with acute ischemic stroke and Internal Carotid ARtery Occlusion: the ICARO study. Stroke. 2012;43(1):125-30. doi: 10.1161/STROKEAHA.111.630624.
3. Hacke W., Kaste M., Bluhmki E., Brozman M., Dávalos A., Guidetti D., Larrue V., Lees K.R., Medeghri Z., Machnig T., Schneider D., von Kummer R., Wahlgren N., Toni D.; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 Sep 25;359(13):1317-29. doi: 10.1056/NEJMoa0804656.
4. G. J. Del Zoppo, R. T. Higashida, A. J. Furlan, M. S. Pessin, H. A. Rowley, and M. Gent, PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke. 1998;29(1):4-11. doi:10.1161/01.str.29.1.4.
5. Ogawa A., Mori E., Minematsu K., Taki W., Takahashi A., Nemoto S., Miyamoto S., Sasaki M., Inoue T.; MELT Japan Study Group. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke.
6. 2007;38(10):2633-9. doi: 10.1161/STROKEAHA.107.488551.
7. Tirschwell D. Intra-arterial prourokinase for acute ischemic stroke. JAMA. 2000;283(16):2103; author reply 2103-4. Comment on: Furlan A., Higashida R., Wechsler L., Gent M., Rowley H., Kase C., Pessin M., Ahuja A., Callahan F., Clark W.M., Silver F., Rivera F. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282(21):2003-11. doi:10.1001/jama.282.21.2003
8. Smith W.S., Sung G., Starkman S., Saver J.L., Kidwell C.S., Gobin Y.P., Lutsep H.L., Nesbit G.M., Grobelny T., Rymer M.M., Silverman I.E., Higashida R.T., Budzik R.F., Marks M.P.; MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke. 2005 Jul;36(7):1432-8. doi: 10.1161/01.STR.0000171066.25248.1d.
9. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, Lutsep HL, Rymer MM, Higashida RT, Starkman S, Gobin YP; Multi MERCI Investigators, Frei D, Grobelny T, Hellinger F, Huddle D, Kidwell C, Koroshetz W, Marks M, Nesbit G, Silverman IE. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke. 2008;39(4):1205-12. doi: 10.1161/STROKEAHA.107.497115.
10. Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke. 2009;40(8):2761-8. doi: 10.1161/STROKEAHA.108.544957.
11. Levy E.I., Siddiqui A.H., Crumlish A., Snyder K.V., Hauck E.F., Fiorella D.J., Hopkins L.N., Mocco J. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke. 2009 Nov;40(11):3552-6. doi: 10.1161/STROKEAHA.109.561274.
12. KühnA.L., Vardar Z., KraitemA., King R.M.,Anagnostakou V., Puri A.S., Gounis M.J. Biomechanics and hemodynamics of stent-retrievers. J Cereb Blood Flow Metab. 2020;40(12):2350-2365. doi: 10.1177/0271678X20916002.
13. Saver J.L., Jahan R., Levy E.I., Jovin T.G., Baxter B., Nogueira R.G., Clark W., Budzik R., Zaidat O.O.; SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012;380(9849):1241-9. doi: 10.1016/S0140-6736(12)61384-1.
14. Nogueira R.G., Lutsep H.L., Gupta R., Jovin T.G., Albers G.W., Walker G.A., Liebeskind D.S., Smith W.S.; TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 2012;380(9849):1231-40. doi: 10.1016/S0140-6736(12)61299-9.
15. Broderick J.P., Palesch Y.Y., Demchuk A.M., Yeatts S.D., Khatri P., Hill M.D., Jauch E.C., Jovin T.G., Yan B., Silver F.L. et al.; Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368(10):893-903. doi: 10.1056/NEJMoa1214300.
16. Ciccone A., Valvassori L., Nichelatti M., Sgoifo A., Ponzio M., Sterzi R., Boccardi E.; SYNTHESIS Expansion Investigators. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013;368(10):904-13. doi: 10.1056/NEJMoa1213701
17. Kidwell C.S., Jahan R., Gornbein J., Alger J.R., Nenov V., Ajani Z., Feng L., Meyer B.C., Olson S., Schwamm L.H., Yoo A.J., Marshall R.S., Meyers P.M., Yavagal D.R., Wintermark M., Guzy J., Starkman S., Saver J.L.; MR RESCUE Investigators. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368(10):914-23. doi: 10.1056/NEJMoa1212793.
18. Berkhemer O.A., Fransen P.S., Beumer D., van den Berg L.A., Lingsma H.F., Yoo A.J., Schonewille W.J., Vos J.A., Nederkoorn P.J., Wermer M.J., van Walderveen M.A. et al.; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11-20. doi:10.1056/NEJMoa1411587.
19. Goyal M., Demchuk A.M., Menon B.K., Eesa M., Rempel J.L., Thornton J., Roy D., Jovin T.G., Willinsky R.A., Sapkota B.L. et al.; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019-30. doi: 10.1056/NEJMoa1414905.
20. Saver J.L., Goyal M., Bonafe A., Diener H.C., Levy E.I., Pereira V.M., Albers G.W., Cognard C., Cohen D.J., Hacke W. et al.; SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372(24):2285-95. doi: 10.1056/NEJMoa1415061.
21. Campbell B.C., Mitchell P.J., Kleinig T.J., Dewey H.M., Churilov L., Yassi N., Yan B., Dowling R.J., Parsons M.W., Oxley T.J. et al.; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372(11):1009-18. doi: 10.1056/NEJMoa1414792.
22. Jovin T.G., Chamorro A., Cobo E., de Miquel M.A., Molina C.A., RoviraA., San Román L., Serena J.,Abilleira S., Ribó M., Millán M., Urra X., Cardona P., López-Cancio E., Tomasello A., Castaño C., Blasco J., Aja L., Dorado L., Quesada H., Rubiera M., Hernandez-Pérez M., Goyal M., Demchuk A.M., von Kummer R., Gallofré M., Dávalos A.; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372(24):2296-306. doi: 10.1056/NEJMoa1503780.
23. Goyal M., Menon B.K., van Zwam W.H., Dippel D.W., Mitchell P.J., Demchuk A.M., Dávalos A., Majoie C.B., van der Lugt A., de Miquel M.A. et al.; HERMES collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723-31. doi: 10.1016/S0140-6736(16)00163-X.
24. Puig J., Shankar J., Liebeskind D., Terceño M., Nael K., Demchuk A.M., Menon B., Dowlatshahi D., Leiva-Salinas C., Wintermark M., Thomalla G., Silva Y., Serena J., Pedraza S., Essig M. From "Time is Brain" to "Imaging is Brain": A Paradigm Shift in the Management of Acute Ischemic Stroke. J Neuroimaging. 2020;30(5):562-571. doi: 10.1111/jon.12693..
25. Jovin T.G., Liebeskind D.S., Gupta R., Rymer M., Rai A., Zaidat O.O., Abou-Chebl A., Baxter B., Levy E.I., Barreto A., Nogueira R.G. Imaging-based endovascular therapy for acute ischemic stroke due to proximal intracranial anterior circulation occlusion treated beyond 8 hours from time last seen well: retrospective multicenter analysis of 237 consecutive patients. Stroke. 2011;42(8):2206-11. doi: 10.1161/ STROKEAHA.110.604223.
26. Nogueira R.G., Jadhav A.P., Haussen D.C., Bonafe A., Budzik R.F., Bhuva P., Yavagal D.R., Ribo M., Cognard C., Hanel R.A. et al. ; DAWN Trial Investigators. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018;378(1):11-21. doi: 10.1056/NEJMoa1706442.
27. Albers G.W., Marks M.P., Kemp S., Christensen S., Tsai J.P., Ortega-Gutierrez S., McTaggart R.A., Torbey M.T., Kim-Tenser M., Leslie-Mazwi T. et al. ; DEFUSE 3 Investigators. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018;378(8):708-718. doi: 10.1056/NEJMoa1713973.
28. Powers W.J., Rabinstein A.A., Ackerson T., Adeoye O.M., Bambakidis N.C., Becker K., Biller J., Brown M., Demaerschalk B.M., Hoh B., Jauch E.C., Kidwell C.S., Leslie-Mazwi T.M., Ovbiagele B., Scott P.A., Sheth K.N., Southerland A.M., Summers D.V., Tirschwell D.L. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344-e418. doi: 10.1161/STR.0000000000000211.
29. Turc G., Bhogal P., Fischer U., Khatri P., Lobotesis K., Mazighi M., Schellinger P.D., Toni D., de Vries J., White P., Fiehler J. European Stroke Organisation (ESO) - European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischaemic StrokeEndorsed by Stroke Alliance for Europe (SAFE). Eur Stroke J. 2019;4(1):6-12. doi: 10.1177/2396987319832140.
30. Schramm P., Navia P., Papa R., Zamarro J., Tomasello A., Weber W., Fiehler J., Michel P., Pereira V.M., Krings T., Gralla J., Santalucia P., Pierot L., Lo T.H. ADAPT technique with ACE68 and ACE64 reperfusion catheters in ischemic stroke treatment: results from the PROMISE study. J Neurointerv Surg. 2019;11(3):226-231. doi: 10.1136/neurintsurg-2018-014122.
31. Stampfl S., Kabbasch C., Müller M., Mpotsaris A., Brockmann M., Liebig T., Wiesmann M., Bendszus M., Möhlenbruch M.A. Initial experience with a new distal intermediate and aspiration catheter in the treatment of acute ischemic stroke: clinical safety and efficacy. J Neurointerv Surg. 2016;8(7):714-8. doi: 10.1136/neurintsurg-2015-011801.
32. Lapergue B., Blanc R., Gory B., Labreuche J., Duhamel A., Marnat G., Saleme S., Costalat V., Bracard S., Desal H., Mazighi M., Consoli A., Piotin M.; ASTER Trial Investigators. Effect of Endovascular Contact Aspiration vs Stent Retriever on Revascularization in Patients With Acute Ischemic Stroke and Large Vessel Occlusion: The ASTER Randomized Clinical Trial. JAMA. 2017;318(5):443-452. doi: 10.1001/jama.2017.9644.
33. Turk A.S. 3rd, Siddiqui A., Fifi J.T., De Leacy R.A., Fiorella D.J., Gu E., Levy E.I., Snyder K.V., Hanel R.A., Aghaebrahim A., Woodward B.K., Hixson H.R., Chaudry M.I., Spiotta A.M., Rai A.T., Frei D., Almandoz J.E.D., Kelly M., Arthur A., Baxter B., English J., Linfante I., Fargen K.M., Mocco J. Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS): a multicentre, randomised, open label, blinded outcome, non-inferiority trial. Lancet. 2019;393(10175):998-1008. doi: 10.1016/S0140-6736(19)30297-1.
34. Delgado Almandoz J.E., Kayan Y., Young M.L, Fease J.L., Scholz J.M., Milner A.M., Hehr T.H., Roohani P., Mulder M., Tarrel R.M. Comparison of clinical outcomes in patients with acute ischemic strokes treated with mechanical thrombectomy using either Solumbra or ADAPT techniques. J Neurointerv Surg. 2016;8(11):1123-1128. doi: 10.1136/neurintsurg-2015-012122.
35. Massari F., Henninger N., Lozano J.D., Patel A., Kuhn A.L., Howk M., Perras M., Brooks C., Gounis M.J., Kan P., Wakhloo A.K., Puri A.S. ARTS (Aspiration-Retriever Technique for Stroke): Initial clinical experience. Interv Neuroradiol. 2016;22(3):325-32. doi: 10.1177/1591019916632369.
36. Nikoubashman O., Alt J.P., Nikoubashman A., Büsen M., Heringer S., Brockmann C., Brockmann M.A., Müller M., Reich A., Wiesmann M. Optimizing endovascular stroke treatment: removing the microcatheter before clot retrieval with stent-retrievers increases aspiration flow. J Neurointerv Surg. 2017;9(5):459-462. doi: 10.1136/neurintsurg-2016-012319.
37. Maus V., Behme D., Kabbasch C., Borggrefe J., Tsogkas I., Nikoubashman O., Wiesmann M., Knauth M., Mpotsaris A., Psychogios M.N. Maximizing First-Pass Complete Reperfusion with SAVE. Clin Neuroradiol. 2018;28(3):327-338. doi: 10.1007/s00062-017-0566-z.
38. Goyal M., Menon B.K., van Zwam W.H., Dippel D.W., Mitchell P.J., Demchuk A.M., Dávalos A., Majoie C.B., van der Lugt A., de Miquel M.A., Donnan G.A. et al.; HERMES collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723-31. doi: 10.1016/S0140-6736(16)00163-X.
39. Kurisu K., Yenari M.A. Therapeutic hypothermia for ischemic stroke; pathophysiology and future promise. Neuropharmacology. 2018;134(Pt B):302-309. doi: 10.1016/j.neuropharm.2017.08.025.
40. Patel R.A.G., McMullen P.W. Neuroprotection in the Treatment of Acute Ischemic Stroke. Prog Cardiovasc Dis. 2017;59(6):542-548. doi: 10.1016/j.pcad.2017.04.005.
41. Caroff J., King R.M., Mitchell J.E., Marosfoi M., Licwinko J.R., Gray-Edwards H.L., Puri A.S., Merrill T.L., Gounis M.J. Focal cooling of brain parenchyma in a transient large vessel occlusion model: proof-of-concept. J Neurointerv Surg. 2020;12(2):209-213. doi: 10.1136/neurintsurg-2019-015179.
42. Fartakov Е., Lomivorotov В., Malaev Д., Tarkova А., Boykov А., Prokhorikhin А., Volchenko Д., Zykov И., Seleznev П., Baystrukov В., Grachev Н., Sergeevichev Д., Chernyavskiy А., & Kretov Е. (2020). Effects of selective intracarotid cerebral hypothermia on the size of ischaemic stroke in an experiment. Patologiya Krovoobrashcheniya I Kardiokhirurgiya. 2020;24(3):112–120. doi:10.21688/1681-3472-2020-3-112-120 (In Russian)
43. Wu C., Zhao W., An H., Wu L., Chen J., Hussain M., Ding Y., Li C., Wei W., Duan J., Wang C., Yang Q., Wu D., Liu L., Ji X. Safety, feasibility, and potential efficacy of intraarterial selective cooling infusion for stroke patients treated with mechanical thrombectomy. J Cereb Blood Flow Metab. 2018;38(12):2251-2260. doi: 10.1177/0271678X18790139.
44. Fraser J.F., Maniskas M., Trout A., Lukins D., Parker L., Stafford W.L., Alhajeri A., Roberts J., Bix G.J. Intra-arterial verapamil post-thrombectomy is feasible, safe, and neuroprotective in stroke. J Cereb Blood Flow Metab. 2017;37(11):3531-3543. doi:10.1177/0271678X17705259..
45. Hill M.D., Goyal M., Menon B.K., Nogueira R.G., McTaggart R.A., Demchuk A.M., Poppe A.Y., Buck B.H., Field T.S., Dowlatshahi D.; ESCAPE-NA1 Investigators. Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. Lancet. 2020;395(10227):878-887. doi: 10.1016/S0140-6736(20)30258-0.
46. Dávalos A., Alvarez-Sabín J., Castillo J., Díez-Tejedor E., Ferro J., Martínez-Vila E., Serena J., Segura T., Cruz V.T., Masjuan J., Cobo E., Secades J.J.; International Citicoline Trial on acUte Stroke (ICTUS) trial investigators. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet. 2012;380(9839):349-57. doi: 10.1016/S0140-6736(12)60813-7.
47. Guekht A., Vester J., Heiss W.D., Gusev E., Hoemberg V., Rahlfs V.W., Bajenaru O., Popescu B.O., Doppler E., Winter S., Moessler H., Muresanu D. Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials. Neurol Sci. 2017;38(10):1761-1769. doi: 10.1007/s10072-017-3037-z.
48. Zhang J., Liu J., Li D., Zhang C., Liu M. Calcium antagonists for acute ischemic stroke. Cochrane Database Syst Rev. 2019;2(2):CD001928. doi: 10.1002/14651858.CD001928.pub3.
Review
For citations:
Malaev D.U., Grachev N.I., Redkin D.A. Endovascular treatments for ischemic stroke. Complex Issues of Cardiovascular Diseases. 2022;11(3):188-198. (In Russ.) https://doi.org/10.17802/2306-1278-2022-11-3-188-198
Views:
723
